Mitochondrial Medicine Society Update (2016) - Dr. Amy Goldstein - 4/3/2016

October 21, 2020 01:04:57
Mitochondrial Medicine Society Update (2016) - Dr. Amy Goldstein - 4/3/2016
MitoAction Expert Series
Mitochondrial Medicine Society Update (2016) - Dr. Amy Goldstein - 4/3/2016

Oct 21 2020 | 01:04:57

/

Show Notes

Dr. Amy Goldstein provides an update on the Mitochondrial Medicine Society.

Areas of discussion include:

Centers of Excellence and the need for community involvement/input

About the Speaker

Dr. Amy Goldstein, a member of the Board of Trustees of UMDF, is on faculty at Children’s Hospital of Pittsburgh of UPMC in the Division of Pediatric Neurology. She is board certified in pediatrics, neurology, and psychiatry with Special Qualifications in Child Neurology. She is currently an Assistant Professor at the University of Pittsburgh School of Medicine. She began a multidisciplinary Mitochondrial Disease clinic in 2007 and is now the Director of Neurogenetics & Metabolism and the site Principle Investigator for NAMDC (the North American Mitochondrial Disease Consortium). She is also President of the Mitochondrial Medicine Society. Her clinical research interests include improving fatigue and exercise intolerance as well as developing common patient-centered outcome measures for clinical trials.

 

To view the accompanying slides, click here.

Other Episodes

Episode 0

October 11, 2021 00:55:21
Episode Cover

The Mito Cocktail Revisited

Join MitoAction and Acton Pharmacy’s Clinical Pharmacist, Ted Toufas as we revisit and provide the latest updates about the mito cocktail! The mito cocktail...

Listen

Episode

March 08, 2025 01:22:27
Episode Cover

Expert Series: Ins and Outs of the Mito Cocktail: Pat 1 of 2

In the, “Ins and Outs of the Mito Cocktail: Part 1 of 2,” Dr. Toufas will explore how our bodies digest and absorb nutrients...

Listen

Episode 0

June 18, 2020 01:08:13
Episode Cover

Is It Really Mito? - Dr. Fran Kendall - 2/20/18

Dr. Fran Kendall of VMP Genetics discusses “Is it really Mito? When an alternative diagnosis should be considered.” Talking points include: Clinical red flags...

Listen